An update on locoregional percutaneous treatment technologies in colorectal cancer liver metastatic disease
S Spiliopoulos, O Moschovaki-Zeiger… - Expert Review of …, 2023 - Taylor & Francis
Introduction Liver-dominant metastatic colorectal cancer is noted in approximately 20%–
35% of the patients. Systemic chemotherapy remains the first-line treatment for mCRC, but …
35% of the patients. Systemic chemotherapy remains the first-line treatment for mCRC, but …
Local treatments in the unresectable patient with colorectal cancer metastasis: a review from the point of view of the medical oncologist
J Torres-Jiménez, J Esteban-Villarrubia… - Cancers, 2021 - mdpi.com
Simple Summary Local treatments represent a potential curative approach in the patient with
liver metastases of colorectal origin. It is important for all the team involved in patient care to …
liver metastases of colorectal origin. It is important for all the team involved in patient care to …
[HTML][HTML] First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac
TM Janssen, K Aitken, F Alongi, A Barry… - Technical Innovations & …, 2022 - Elsevier
The treatment of oligometastatic disease using MR guidance is an evolving field. Since
August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current …
August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current …
The emerging role of local therapy in oligometastatic non–small cell lung cancer
Feature Editor Introduction—Local therapy for oligometastatic non–small cell lung cancer
(NSCLC) is a complex and controversial topic that continues to evolve. With advances in …
(NSCLC) is a complex and controversial topic that continues to evolve. With advances in …
Oligometastases in head and neck squamous cell carcinoma patients
Despite improvements in locoregional control due to developments in surgery, radiation
therapy and systemic therapy, little improvement has been achieved in terms of survival …
therapy and systemic therapy, little improvement has been achieved in terms of survival …
Stereotactic Body Radiotherapy in Recurrent and Oligometastatic Head and Neck Tumours
The treatment of head and neck cancers (HNCs) encompasses a complex paradigm
involving a combination of surgery, radiotherapy, and systemic treatment. Locoregional …
involving a combination of surgery, radiotherapy, and systemic treatment. Locoregional …